comparemela.com

Latest Breaking News On - Externalized human immune system - Page 1 : comparemela.com

Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development

Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Prellis Biologics Raises $35M in Series C Funding

Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune

Former Generate Biomedicines, Amgen and Novartis senior leader Mike Nohaile joins Prellis as CEOSAN FRANCISCO (BUSINESS WIRE) Prellis Biologics, Inc (Prellis Bio), a biotherapeutics company, today appointed Michael Nohaile, PhD as its new CEO and announced it has raised a $35 million Series C funding round, co-led.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.